Once These Biotech Stocks Settle Down, I’m All Over Them
As second-quarter earnings powers the market higher, I’m waiting for a chance to add to these two stocks.
Investors Turn Bullish on This Biotech Stock Heading Into Catalyst
Breadth holds up while chips fall, and this biotech chart is setting up ahead of earnings season.
Investors Are Nervous. I’m Getting Interested.
Dislocations driven by market conditions rather than fundamentals are creating my shopping list.
Stocks & Markets Podcast: Regenerative Medicine’s Next Leap with Conexeu Sciences CEO
Leveraging wound care to tackle the much larger aesthetics market.
These Two Biotechs Offer Stability in a Crazy Market
A slow and steady approach with these stable biopharma stocks offers refuge from a market that feels ready to pop.
Will the SK Hynix IPO Repeat the SpaceX Pattern?
As SKHY’s debut grabs the spotlight, the real test for the market starts next week with these three things.
I Don’t Know About You, But I’m Feeling These 22 Biotech Stocks
The market is in a transitional phase as we await earnings.
I’ve Got Some Biotech ‘IRON’s in the Fire
Here are two cover-call trades I’m working on and why they look promising.
The Iran War Is Back and Causing Broader Market Weakness
Rotational action has been a safe haven, but it is now under pressure.
Strong Rotation Prevents Broad Weakness as SpaceX Joins the Nasdaq 100
The market looks tired on Monday morning, but there is some rebound in chip names.